Last updated on September 2017

Study of Efficacy and Safety of Secukinumab in Patients With Ankylosing Spondylitis


Brief description of study

To demonstrate the clinical efficacy, safety and tolerability of secukinumab compared to placebo in patients with ankylosing spondylitis at Week 16 and long term efficacy and safety up to Week 52.

Clinical Study Identifier: NCT02896127

.

Contact Investigators or Research Sites near you

Start Over

Please choose location

View all locations

Novartis Pharmaceuticals

Novartis Investigative Site
Hefei, China
  Connect »

Novartis Pharmaceuticals

Novartis Investigative Site
Beijing, China
  Connect »

Novartis Pharmaceuticals

Novartis Investigative Site
Guangzhou, China
  Connect »

Novartis Pharmaceuticals

Novartis Investigative Site
Wuhan, China
  Connect »

Novartis Pharmaceuticals

Novartis Investigative Site
Changsha, China
  Connect »

Novartis Pharmaceuticals

Novartis Investigative Site
Nanjing, China
  Connect »

Novartis Pharmaceuticals

Novartis Investigative Site
Shanghai, China
  Connect »

Novartis Pharmaceuticals

Novartis Investigative Site
Shanxi Province, China
  Connect »

Novartis Pharmaceuticals

Novartis Investigative Site
Tianjin, China
  Connect »

Novartis Pharmaceuticals

Novartis Investigative Site
Zhejiang, China
  Connect »

Novartis Pharmaceuticals

Novartis Investigative Site
Bruntal, Czechia
  Connect »

Novartis Pharmaceuticals

Novartis Investigative Site
Ostrava, Czechia
  Connect »

Novartis Pharmaceuticals

Novartis Investigative Site
Praha 11, Czechia
  Connect »

Novartis Pharmaceuticals

Novartis Investigative Site
Praha 2, Czechia
  Connect »

Novartis Pharmaceuticals

Novartis Investigative Site
Uherske Hradiste, Czechia
  Connect »

Novartis Pharmaceuticals

Novartis Investigative Site
Busan, Korea, Republic of
  Connect »

Novartis Pharmaceuticals

Novartis Investigative Site
Gwangju, Korea, Republic of
  Connect »

Novartis Pharmaceuticals

Novartis Investigative Site
Incheon, Korea, Republic of
  Connect »

Novartis Pharmaceuticals

Novartis Investigative Site
Seoul, Korea, Republic of
  Connect »

Novartis Pharmaceuticals

Novartis Investigative Site
Reading, United Kingdom
  Connect »

Novartis Pharmaceuticals

Novartis Investigative Site
Bradford, United Kingdom
  Connect »

Novartis Pharmaceuticals

Novartis Investigative Site
Bath, United Kingdom
  Connect »

Novartis Pharmaceuticals

Novartis Investigative Site
Doncaster, United Kingdom
  Connect »

Novartis Pharmaceuticals

Novartis Investigative Site
Hull, United Kingdom
  Connect »

Novartis Pharmaceuticals

Novartis Investigative Site
London, United Kingdom
  Connect »

Novartis Pharmaceuticals

Novartis Investigative Site
Norwich, United Kingdom
  Connect »

Novartis Pharmaceuticals

Novartis Investigative Site
Southampton, United Kingdom
  Connect »

Novartis Pharmaceuticals

Novartis Investigative Site
Wigan, United Kingdom
  Connect »